Back
Royal Caribbean Group Vs. Arcus Biosciences Industry Stock Comparison
Buy
66
RCL
Royal Caribbean Group
Last Price:
138.19
Seasonality Move:
2.11%
Buy
53
RCUS
Arcus Biosciences
Last Price:
15.66
Seasonality Move:
-8.68%
Buy
66
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $138.21. The Score for RCL is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Arcus Biosciences (RCUS)
is a Buy
Is Arcus Biosciences a Buy, Sell or Hold?
- The current Arcus Biosciences [RCUS] share price is $15.70. The Score for RCUS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- RCUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $138.21
The current trend is moderately bullish and RCL is experiencing selling pressure, which indicates risk of future bearish movement.
RCUS Stock Price Chart
What is Arcus Biosciences's stock price today?
-
The Arcus Biosciences share price today is $15.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing selling pressure, which indicates risk of future bearish movement.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2 | Buy |
| Relative Strength Index (14 RSI): | 56.86 | Buy |
| Chaikin Money Flow: | -1777202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.01 - 139.55) | Buy |
| Bollinger Bands (100): | (120.42 - 134.22) | Buy |
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 46.57 | Sell |
| Chaikin Money Flow: | -278305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.03 - 17.25) | Sell |
| Bollinger Bands (100): | (15.55 - 18.61) | Sell |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.86 | Sell |
| 20-day SMA: | 134.1 | Buy |
| 50-day SMA: | 131.97 | Buy |
| 200-day SMA: | 112.55 | Buy |
| 8-day EMA: | 137.7 | Buy |
| 20-day EMA: | 135.64 | Buy |
| 50-day EMA: | 131.9 | Buy |
| 200-day EMA: | 114.02 | Buy |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.41 | Buy |
| 20-day SMA: | 15.75 | Sell |
| 50-day SMA: | 17.26 | Sell |
| 200-day SMA: | 17.37 | Sell |
| 8-day EMA: | 15.48 | Buy |
| 20-day EMA: | 15.82 | Sell |
| 50-day EMA: | 16.5 | Sell |
| 200-day EMA: | 17.61 | Sell |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $1.59 per share, an increase this year of $4.27 per share, and an increase next year of $1.65 per share.
Arcus Biosciences Earnings Growth & RCUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.21 per share.
Royal Caribbean Group Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcus Biosciences Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||